Susquehanna International Group, LLP Emergent Bio Solutions Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$5.72 - $14.77 $493,636 - $1.27 Million	86,300 Added 68.76%	211,800 $1.77 Million
Q2 2024 Aug 15, 2024	BUY	$1.86 - $6.98 $186,930 - $701,490	100,500 Added 402.0%	125,500 $855,000
Q1 2024 May 07, 2024	BUY	$1.5 - $3.41 $37,500 - $85,250	25,000 New	25,000 $63,000
Q4 2022 Feb 14, 2023	BUY	$11.0 - $21.45 $313,500 - $611,325	28,500 New	28,500 $336,000
Q2 2022 Aug 15, 2022	BUY	$27.42 - $43.63 $348,234 - $554,101	12,700 Added 26.68%	60,300 $1.87 Million
Q1 2022 May 16, 2022	SELL	$36.48 - $52.22 $167,808 - $240,212	-4,600 Reduced 8.81%	47,600 $1.95 Million
Q4 2021 Feb 14, 2022	BUY	$33.11 - $55.01 $1.11 Million - $1.84 Million	33,500 Added 179.14%	52,200 $2.27 Million
Q3 2021 Nov 15, 2021	SELL	$50.07 - $66.05 $1.01 Million - $1.33 Million	-20,100 Reduced 51.8%	18,700 $936,000
Q2 2021 Aug 11, 2021	BUY	$56.61 - $80.46 $124,542 - $177,012	2,200 Added 6.01%	38,800 $2.44 Million
Q1 2021 May 17, 2021	SELL	$86.23 - $125.19 $3.48 Million - $5.06 Million	-40,400 Reduced 52.47%	36,600 $3.4 Million
Q4 2020 Feb 16, 2021	BUY	$79.17 - $111.47 $2.24 Million - $3.15 Million	28,300 Added 58.11%	77,000 $6.9 Million
Q3 2020 Nov 16, 2020	BUY	$81.91 - $134.94 $819,100 - $1.35 Million	10,000 Added 25.84%	48,700 $5.03 Million
Q2 2020 Aug 14, 2020	BUY	$54.33 - $89.52 $1.39 Million - $2.29 Million	25,600 Added 195.42%	38,700 $3.06 Million
Q1 2020 May 15, 2020	BUY	$49.34 - $68.76 $355,248 - $495,072	7,200 Added 122.03%	13,100 $758,000
Q4 2019 Feb 14, 2020	SELL	$51.21 - $59.06 $5,121 - $5,906	-100 Reduced 1.67%	5,900 $318,000
Q3 2019 Nov 14, 2019	SELL	$40.6 - $57.2 $832,300 - $1.17 Million	-20,500 Reduced 77.36%	6,000 $314,000
Q1 2019 May 15, 2019	BUY	$48.23 - $66.16 $434,070 - $595,440	9,000 Added 51.43%	26,500 $1.34 Million
Q4 2018 Feb 14, 2019	SELL	$55.63 - $73.24 $317,091 - $417,467	-5,700 Reduced 24.57%	17,500 $1.04 Million
Q3 2018 Nov 14, 2018	BUY	$52.05 - $66.51 $156,150 - $199,530	3,000 Added 14.85%	23,200 $1.53 Million
Q1 2018 May 15, 2018	BUY	$44.44 - $54.39 $693,264 - $848,484	15,600 Added 339.13%	20,200 $1.06 Million
Q4 2017 Feb 14, 2018	SELL	$37.77 - $47.75 $2.34 Million - $2.96 Million	-61,900 Reduced 93.08%	4,600 $214,000
Q3 2017 Nov 14, 2017	BUY	$34.14 - $40.45 $2.27 Million - $2.69 Million	66,500	66,500 $2.69 Million

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$34.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$30.1 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$22.1 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$19.7 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$17 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $442M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account